Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sézary Syndrome”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableLooking for participantsNCT02848274
What this trial is testing

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Who this might be right for
Mycosis FungoidesNon-Hodgkin's Lymphoma
Stanford University 2,000
Testing effectiveness (Phase 2)Ended earlyNCT00490776
What this trial is testing

Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 9
Not applicableLooking for participantsNCT06588868
What this trial is testing

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS 400
Testing effectiveness (Phase 2)Looking for participantsNCT05996185
What this trial is testing

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Who this might be right for
T Cell LymphomaT-cell Lymphoma
Yale University 22
Not applicableLooking for participantsNCT07003100
What this trial is testing

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Who this might be right for
Recurrent Mycosis FungoidesRecurrent Sezary SyndromeRefractory Mycosis Fungoides+6 more
City of Hope Medical Center 100
Not applicableLooking for participantsNCT06382844
What this trial is testing

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

Who this might be right for
Cutaneous T-Cell Lymphoma
Instituto de Investigación Biomédica de Salamanca 100
Early research (Phase 1)Looking for participantsNCT04234048
What this trial is testing

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Who this might be right for
T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell Lymphoma+8 more
SciTech Development, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT00431912
What this trial is testing

APO866 for the Treatment of Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
Valerio Therapeutics 25
Early research (Phase 1)Study completedNCT00554827
What this trial is testing

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc. 55
Testing effectiveness (Phase 2)WithdrawnNCT00969085
What this trial is testing

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Who this might be right for
Cutaneous T-cell Lymphoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00425555
What this trial is testing

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 139
Post-approval studies (Phase 4)Active Not RecruitingNCT06285370
What this trial is testing

Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy

Who this might be right for
Cutaneous T-Cell Lymphoma
Kyowa Kirin China Pharmaceutical Co., Ltd. 23
Testing effectiveness (Phase 2)Looking for participantsNCT04256018
What this trial is testing

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

Who this might be right for
Sezary SyndromeMycosis Fungoides
Stanford University 30
Testing effectiveness (Phase 2)Study completedNCT00057967
What this trial is testing

Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 37
Early research (Phase 1)Active Not RecruitingNCT05944562
What this trial is testing

Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome

Who this might be right for
Mycosis FungoidesSezary SyndromeMycosis Fungoides/Sezary Syndrome
Washington University School of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT02953301
What this trial is testing

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

Who this might be right for
Mycosis FungoidesSezary SyndromeLymphoma, T-Cell, Cutaneous
4SC AG 201
Not applicableActive Not RecruitingNCT05455931
What this trial is testing

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

Who this might be right for
Mycosis Fungoides and Sézary Syndrome
Kyowa Kirin Pharmaceutical Development Ltd 73
Not applicableLooking for participantsNCT04904146
What this trial is testing

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Who this might be right for
Mycosis FungoidesSezary Syndrome
Lund University Hospital 120
Early research (Phase 1)Active Not RecruitingNCT04652960
What this trial is testing

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

Who this might be right for
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04960618
What this trial is testing

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Mycosis FungoidesMycosis Fungoides/Sezary SyndromeSezary Syndrome+2 more
Memorial Sloan Kettering Cancer Center 14
Load More Results